Affinity Asset Advisors »

Compass Pathways shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.0M 501k 6.04
2024-03-31 $8.6M 1.0M 8.32
2023-12-31 $4.8M 550k 8.75

More positions owned by Affinity Asset Advisors

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Madrigal Pharmaceuticals (MDGL)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Celldex Therapeutics Com New (CLDX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Beigene Sponsored Adr (BGNE)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)

View all positions for Affinity Asset Advisors

Top funds holding Compass Pathways

TCG Crossover Management
Citadel Advisors
Millennium Management
Paradigm Biocapital Advisors
ARK Investment Management
Logos Global Management
Partner Fund Management
Aisling Capital Management
Rosalind Advisors
Laurion Capital Management
Affinity Asset Advisors
Barclays
BlackRock
Susquehanna International
Two Sigma Investments

View all funds holding Compass Pathways